Log In
Print
BCIQ
Print
Print this Print this
 

serelaxin (RLX030) (formerly ConXn)

Also known as: Relaxin

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionRecombinant human relaxin-H2
Molecular Target Relaxin-insulin-like family peptide receptor 2 (RXFP2) (LGR8) (GPR106)
Mechanism of ActionRelaxin receptor agonist
Latest Stage of DevelopmentRegistration
IndicationHeart failure
Partner

GlaxoSmithKline plc; Paladin Labs Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today